MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing.

Related Keywords

Japan ,United Kingdom ,Exeter ,Devon ,Oliver Sexton ,Jon Rees ,Daniel Gooch ,Hideo Kimura ,Harwell Oxford ,Matt Whiteman ,Sanyo Onoda City University ,Science Angel Syndicate Network ,United Kingdom Innovation Science Seed Fund ,Linkedin ,Twitter ,Fink Family Office ,Media Contact Scius Communications ,University Of Exeter ,Company Contact Mitorx ,Oxford Technology Management ,Appoints Industry Veteran Glyn Edwards ,Glyn Edwards ,Prof Matt Whiteman ,Norman Law ,Investment Director ,United Kingdom Innovation ,Science Seed Fund ,Mitorx Therapeutic ,Wren Capital ,Scius Communications ,Future Planet Capital ,